✦ LIBER ✦

End-organ resistance to 1,25-dihydroxyvitamin D3: clinical, histologic, and therapeutic observations

✍ Scribed by Weisman, Y.; Hochberg, Z.; Gazit, D.; Spirer, S.; Bab, I.

Book ID: 123412627
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 299 KB
Volume: 7
Category: Article
ISSN: 8756-3282
DOI: 10.1016/8756-3282(86)90309-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vitamin D-resistant rickets: End-organ u

Vitamin D-resistant rickets: End-organ unresponsiveness to 1,25(OH)2D3

✍ Joseph J. Sockalosky; Robert A. Ulstrom; Hector F. DeLuca; David M. Brown 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Vitamin D-dependent rickets type II: ext

Vitamin D-dependent rickets type II: extreme end organ resistance to 1,25-dihydroxy vitamin D3in a patient without alopecia

✍ L. J. Fraher; R. Karmali; F. R. J. Hinde; G. N. Hendy; H. Jani; L. Nicholson; D. 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 689 KB

Vitamin D-dependent rickets type II (VDDR II) is a rare syndrome resulting in severe rickets and is resistant to treatment with vitamin D and its derivatives. Patient with this disease, who are frequently the children of consanguinous marriages, present with elevated circulating concentrations of 1,

Induction of resistance to TNF cytotoxic

Induction of resistance to TNF cytotoxicity and mitochondrial superoxide dismutase on U-937 cells by 1,25-dihydroxyvitamin D3

✍ Sanju Iwamoto; Ken Takeda; Ryutaro Kamijo; Kunio Konno 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 542 KB

Retinoblastoma protein-overexpressing HL

Retinoblastoma protein-overexpressing HL60 cells resistant to 1,25-dihydroxyvitamin D3 display increased CDK2 and CDK6 activity and shortened G1 phase

✍ Wang, Qing Mei; Luo, Xun; Kheir, Ahmed; Coffman, Frederick D; Studzinski, George 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 453 KB

Cultured Psoriatic Fibroblasts from Invo

Cultured Psoriatic Fibroblasts from Involved and Uninvolved Sites Have a Partial but not Absolute Resistance to the Proliferation-Inhibition Activity of 1,25-dihydroxyvitamin D3

✍ J. A. MacLaughlin, W. Gange, D. Taylor, E. Smith and M. F. Holick 📂 Article 📅 1985 🏛 National Academy of Sciences 🌐 English ⚖ 783 KB

The clinical response of psoriatic patie

The clinical response of psoriatic patients to treatment by 1α (OH)vitamin D3 may be predicted by the sensitivity of their peripheral blood mononuclear cells to cAMP elevating agents and to 1,25-dihydroxyvitamin D3

✍ Koren, R.; Ravid, A.; Segal, R.; Maron, L.; Arie, R.; Shohat, B.; David, M.; San 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 204 KB